World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
67
Citations
13211
World Ranking
2700
National Ranking
237

Dean J. Naisbitt publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Dean J. Naisbitt sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 265 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Dean J. Naisbitt D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Dean J. Naisbitt sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 67 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Dean J. Naisbitt is affiliated with the University of Liverpool in the United Kingdom. Their research primarily focuses on medicine, with significant contributions across several subfields including pharmacology, immunology, oncology, pathology and forensic medicine, and rheumatology.

The core topics addressed in Naisbitt's work encompass drug-induced adverse reactions, asthma and respiratory diseases, urticaria and related conditions, drug-induced hepatotoxicity and protection, autoimmune bullous skin diseases, T-cell and B-cell immunology, and mast cells and histamine.

Naisbitt has published extensively, with a notable presence in frequent publication venues such as:

  • Chemical Research in Toxicology
  • Toxicological Sciences
  • Allergy
  • Clinical & Experimental Allergy
  • Journal of Cystic Fibrosis

Their recent papers include:

  • "T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses," 2021, Nature Communications
  • "HLA-B*13:01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients," 2021, Frontiers in Immunology
  • "Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity," 2021, Toxicological Sciences
  • "Identification of Flucloxacillin-Haptenated HLA-B*57:01 Ligands: Evidence of Antigen Processing and Presentation," 2020, Toxicological Sciences
  • "Drug hapten-specific T-cell activation: Current status and unanswered questions," 2021, PROTEOMICS

Frequent co-authors in Naisbitt's collaborative research efforts include Xiaoli Meng, Munir Pirmohamed, Paul Thomson, Monday O. Ogese, and Sean Hammond.

Best Publications

  • Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

    Patricio Godoy;Nicola J. Hewitt;Ute Albrecht;Melvin E. Andersen

  • Managing the challenge of chemically reactive metabolites in drug development

    B. Kevin Park;Alan Boobis;Stephen Clarke;Chris E P Goldring

  • Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

    Gary Middleton;Paul Silcocks;Trevor Cox;Juan Valle

  • Idiosyncratic Adverse Drug Reactions: Current Concepts

    Jack Uetrecht;Dean J. Naisbitt

  • Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones.

    D. J. Naisbitt;M. Britschgi;G. Wong;J. Farrell

  • Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury

    Manal M. Monshi;Lee Faulkner;Andrew Gibson;Rosalind E. Jenkins

  • Characterization of drug-specific T cells in lamotrigine hypersensitivity

    Dean J. Naisbitt;John Farrell;Gavin Wong;Jan p.H. Depta

  • Recognition of Sulfamethoxazole and Its Reactive Metabolites by Drug-Specific CD4+ T Cells from Allergic Individuals

    Benno Schnyder;Christoph Burkhart;Karin Schnyder-Frutig;Salome von Greyerz

  • Immune pathomechanism of drug hypersensitivity reactions

    Werner J. Pichler;Dean J. Naisbitt;B. Kevin Park

  • Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models.

    Richard J Weaver;Eric A Blomme;Amy E Chadwick;Ian M Copple

  • The danger hypothesis--potential role in idiosyncratic drug reactions.

    Munir Pirmohamed;Dean J Naisbitt;Fraser Gordon;B.Kevin Park

  • Challenges and approaches for the development of safer immunomodulatory biologics

    Jean G. Sathish;Swaminathan Sethu;Marie Christine Bielsky;Lolke De Haan

  • Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment.

    Dean J. Naisbitt;Sfraser Gordon;Munir Pirmohamed;Bkevin Park

  • Cellular and Molecular Pathophysiology of Cutaneous Drug Reactions

    Werner J. Pichler;Nikhil Yawalkar;Markus Britschgi;Jan Depta

  • Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine.

    Dominic P. Williams;Munir Pirmohamed;Dean J. Naisbitt;Jack P. Uetrecht

  • Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo

    Dean J Naisbitt;S Fraser Gordon;Munir Pirmohamed;Christoph Burkhart

  • Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity.

    Dean J Naisbitt;Sally J Hough;Helen J Gill;Munir Pirmohamed

  • Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation.

    Dean J. Naisbitt;John Farrell;S. Fraser Gordon;James L. Maggs

  • Activation of T cells by carbamazepine and carbamazepine metabolites.

    Ying Wu;Joseph P. Sanderson;John Farrell;Nicola S. Drummond

  • Metabolic activation in drug allergies.

    B.K. Park;D.J. Naisbitt;S.F. Gordon;N.R. Kitteringham

  • Stimulation of human T cells with sulfonamides and sulfonamide metabolites.

    J. Luis Castrejon;Neil Berry;Sabah El-Ghaiesh;Basil Gerber

  • T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays.

    Stefan F. Martin;Philipp R. Esser;Philipp R. Esser;Sonja Schmucker;Lisa Dietz

Frequent Co-Authors

B. Kevin Park
B. Kevin Park University of Liverpool
Munir Pirmohamed
Munir Pirmohamed University of Liverpool
Neil French
Neil French University of Liverpool
Rosalind E. Jenkins
Rosalind E. Jenkins University of Liverpool
James L. Maggs
James L. Maggs University of Liverpool
Werner J. Pichler
Werner J. Pichler University Hospital of Bern
Paul M. O'Neill
Paul M. O'Neill University of Liverpool
Neil G. Berry
Neil G. Berry University of Liverpool
Ann K. Daly
Ann K. Daly Newcastle University
Ian Kimber
Ian Kimber University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees online can open up various career opportunities. Many students transition into nursing through programs designed for beginners. Exploring online rn programs for non nurses is a great first step for individuals without a medical background seeking to enter the healthcare field quickly and flexibly.

Once foundational nursing knowledge is gained, accelerated options exist for further specialization. Programs labeled as the easiest accelerated nursing programs to get into provide a fast track to earning a Bachelor of Science in Nursing, essential for many advanced clinical roles or stepping into immunology-focused research environments.

If you're starting at a practical nurse level, identifying the easiest lpn programs to get into can be a strategic move. These programs offer quicker entry into healthcare roles, laying the groundwork for future specialization involving immunology.

Finally, for those aiming to advance clinical expertise even further, the easiest np programs to get into are valuable for gaining certifications that open doors to leadership positions and specialized immunology-related practices.

Best Scientists Citing Dean J. Naisbitt

Trending Scientists

Recently Published Articles